Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 242

    1.
    3.

    Lamivudine therapy for children with chronic hepatitis B.

    Liberek A, Szaflarska-Popławska A, Korzon M, Łuczak G, Góra-Gebka M, Łoś-Rycharska E, Bako W, Czerwionka-Szaflarska M.

    World J Gastroenterol. 2006 Apr 21;12(15):2412-6.PMID: 16688835 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    A large population study of spontaneous HBeAg seroconversion and acute exacerbation of chronic hepatitis B infection: implications for antiviral therapy.

    Yuen MF, Yuan HJ, Hui CK, Wong DK, Wong WM, Chan AO, Wong BC, Lai CL.

    Gut. 2003 Mar;52(3):416-9.PMID: 12584226 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Viremia profiles in children with chronic hepatitis B virus infection and spontaneous e antigen seroconversion.

    Ni YH, Chang MH, Chen PJ, Tsai KS, Hsu HY, Chen HL, Tsuei DJ, Chen DS.

    Gastroenterology. 2007 Jun;132(7):2340-5. Epub 2007 Apr 11.PMID: 17570209 [PubMed - indexed for MEDLINE]Related articles

    6.

    [Chronic hepatitis B virus (HBV) infection: usefulness of the combination of HBeAg and ALT determination to predict a high HBV-DNA level and therefore the necessity of referral to a specialist for possible antiviral treatment]

    Veldhuijzen IK, Mostert MC, Niesters HG, Richardus JH, de Man RA.

    Ned Tijdschr Geneeskd. 2008 Jun 21;152(25):1426-30. Dutch. PMID: 18624006 [PubMed - indexed for MEDLINE]Related articles

    7.

    NIH consensus development statement on management of hepatitis B.

    [No authors listed]

    NIH Consens State Sci Statements. 2008 Oct 22-24;25(2):1-29.PMID: 18949020 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Hepatitis B virus DNA prediction rules for hepatitis B e antigen-negative chronic hepatitis B.

    Feld JJ, Ayers M, El-Ashry D, Mazzulli T, Tellier R, Heathcote EJ.

    Hepatology. 2007 Oct;46(4):1057-70.PMID: 17654702 [PubMed - indexed for MEDLINE]Related articles

    9.
    10.

    Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B for up to 5 years.

    Hadziyannis SJ, Tassopoulos NC, Heathcote EJ, Chang TT, Kitis G, Rizzetto M, Marcellin P, Lim SG, Goodman Z, Ma J, Brosgart CL, Borroto-Esoda K, Arterburn S, Chuck SL; Adefovir Dipivoxil 438 Study Group.

    Gastroenterology. 2006 Dec;131(6):1743-51. Epub 2006 Sep 20.PMID: 17087951 [PubMed - indexed for MEDLINE]Related articles

    11.

    Evaluation of alanine transaminase and hepatitis B virus DNA to predict liver cirrhosis in hepatitis B e antigen-negative chronic hepatitis B using transient elastography.

    Wong GL, Wong VW, Choi PC, Chan AW, Chim AM, Yiu KK, Chan HY, Chan FK, Sung JJ, Chan HL.

    Am J Gastroenterol. 2008 Dec;103(12):3071-81.PMID: 19086958 [PubMed - indexed for MEDLINE]Related articles

    12.

    Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level.

    Chen CJ, Yang HI, Su J, Jen CL, You SL, Lu SN, Huang GT, Iloeje UH; REVEAL-HBV Study Group.

    JAMA. 2006 Jan 4;295(1):65-73.PMID: 16391218 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Efficacy of thymosin alpha-1 and interferon alpha in treatment of chronic viral hepatitis B: a randomized controlled study.

    You J, Zhuang L, Cheng HY, Yan SM, Yu L, Huang JH, Tang BZ, Huang ML, Ma YL, Chongsuvivatwong V, Sriplung H, Geater A, Qiao YW, Wu RX.

    World J Gastroenterol. 2006 Nov 7;12(41):6715-21.PMID: 17075991 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Prognostic determinants for chronic hepatitis B in Asians: therapeutic implications.

    Yuen MF, Yuan HJ, Wong DK, Yuen JC, Wong WM, Chan AO, Wong BC, Lai KC, Lai CL.

    Gut. 2005 Nov;54(11):1610-4. Epub 2005 May 4.PMID: 15871997 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Evaluation of the cost-effectiveness of entecavir versus lamivudine in hepatitis BeAg-positive chronic hepatitis B patients.

    Yuan Y, Iloeje UH, Hay J, Saab S.

    J Manag Care Pharm. 2008 Jan-Feb;14(1):21-33.PMID: 18240879 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    [The follow-up of serum aminotransferase levels and investigation of hepatitis B virus load in inactive HBsAg carriers]

    Olut AI, Ozünlü H, Bozdağ H, Ozkalay N.

    Mikrobiyol Bul. 2007 Jul;41(3):429-33. Turkish. PMID: 17933254 [PubMed - indexed for MEDLINE]Related articles

    18.

    Relationship between hepatitis B virus DNA levels and liver histology in patients with chronic hepatitis B.

    Shao J, Wei L, Wang H, Sun Y, Zhang LF, Li J, Dong JQ.

    World J Gastroenterol. 2007 Apr 14;13(14):2104-7.PMID: 17465456 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Treatment recommendations for chronic hepatitis B: an evaluation of current guidelines based on a natural history study in the United States.

    Tong MJ, Hsien C, Hsu L, Sun HE, Blatt LM.

    Hepatology. 2008 Oct;48(4):1070-8.PMID: 18688879 [PubMed - indexed for MEDLINE]Related articles

    20.

    [Can HBsAg levels guide to differentiate inactive HBsAg carriers from HBeAg negative chronic B hepatitis?]

    Sayan M, Mutlu B, Erdoğan S, Meriç M, Willke A.

    Mikrobiyol Bul. 2007 Jan;41(1):87-93. Turkish. PMID: 17427556 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data